SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
SONOMA PHARMACEUTICALS, INC. (SNOA) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $13.68 per share as of 2020-09-30, per its 10-Q filed 2020-11-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2020-11-20
- 2020-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $13.68.
- 2020-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $8.25.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $13.68.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $13.68.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value |
|---|---|
| 2020-09-30 | $13.68 10-Q · filed 2020-11-20 |
| 2020-06-30 | $8.25 10-Q/A · filed 2020-11-17 |
| 2020-03-31 | $13.68 10-Q · filed 2020-11-20 |
| 2019-12-31 | $13.68 10-Q · filed 2020-02-14 |
| 2019-09-30 | $22.58 10-Q · filed 2019-11-14 |
| 2019-06-30 | $48.15 10-Q · filed 2019-08-13 |
| 2019-03-31 | $27.96 10-Q · filed 2020-02-14 |
| 2018-12-31 | $3.18 10-Q · filed 2019-02-14 |
| 2018-09-30 | $3.71 10-Q · filed 2018-11-08 |
| 2018-06-30 | $6.64 10-Q · filed 2018-08-08 |
| 2018-03-31 | $6.46 10-Q · filed 2019-02-14 |
| 2017-12-31 | $6.46 10-Q · filed 2018-02-14 |
| 2017-09-30 | $6.80 10-Q · filed 2017-11-14 |
| 2017-06-30 | $7.19 10-Q · filed 2017-08-08 |
| 2017-03-31 | $7.27 10-Q · filed 2018-02-14 |
| 2016-12-31 | $0.00 10-Q · filed 2017-02-17 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-15 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |